Logo - springer
Slogan - springer

Public Health | Incentives for Research, Development, and Innovation in Pharmaceuticals

Incentives for Research, Development, and Innovation in Pharmaceuticals

Garcia-Fontes, Walter A. (Ed.)

2011, IX, 96 p.

Available Formats:
eBook
Information

Springer eBooks may be purchased by end-customers only and are sold without copy protection (DRM free). Instead, all eBooks include personalized watermarks. This means you can read the Springer eBooks across numerous devices such as Laptops, eReaders, and tablets.

You can pay for Springer eBooks with Visa, Mastercard, American Express or Paypal.

After the purchase you can directly download the eBook file or read it online in our Springer eBook Reader. Furthermore your eBook will be stored in your MySpringer account. So you can always re-download your eBooks.

 
$39.95

(net) price for USA

ISBN 978-84-938062-7-9

digitally watermarked, no DRM

Included Format: PDF

download immediately after purchase


learn more about Springer eBooks

add to marked items

Softcover
Information

Softcover (also known as softback) version.

You can pay for Springer Books with Visa, Mastercard, American Express or Paypal.

Standard shipping is free of charge for individual customers.

 
$59.95

(net) price for USA

ISBN 978-84-938062-1-7

free shipping for individuals worldwide

usually dispatched within 3 to 5 business days


add to marked items

  • In-depth discussion of neglected health economics issues
  • Includes up to date analysis of new data
  • Written by a collection of the leading minds in the field
  • Ground breaking ideas to enhance research and development in the pharmaceutical industry

Incentives for innovation are particularly relevant in the pharmaceutical

industry where not all social needs provide equally profitable

opportunities and where most OECD countries try to implement diffe -

rent measures that promote research in these less profitable areas. The

lack of incentives for innovation is especially dramatic when we take

into account diseases affecting mostly low-income countries, and also

diseases affecting small groups of patients.

How can incentives be provided to deal with these less profitable acti -

vities when no clear markets exist for the innovations being introduced?

Some of the contributions of this book go into discussing alternative

mechanisms to substitute for these inexistent markets, and

situations where traditional instruments such as public procurement or

direct subsidies have proven totally insufficient. Also, this book discusses

the clear mismatch between the size of the markets being targeted and

the incentives being provided.

Content Level » Professional/practitioner

Keywords » Drug develoment - Innovation - Pharmaceutical industry - Research and Development - patent law

Related subjects » Medicine - Public Health

Table of contents 

Introduction.- Incentives for innovation: a survey.- Incentives for innovation: neglected diseases.- When patents are not enough: supplementary incentives for pharmaceutical innovation.- The Contribution of the United States, Europe and Japan in Discovering New Drugs: 1982 2003.- The use of pay for performance for drugs: can it improve incentives for innovation?.- Drug Price Regulation: Recent Trends and Downstream Neglected Issues.

Popular Content within this publication 

 

Articles

Read this Book on Springerlink

Services for this book

New Book Alert

Get alerted on new Springer publications in the subject area of Health Promotion and Disease Prevention.